Suppr超能文献

膀胱腺癌

Adenocarcinoma of bladder.

作者信息

Dandekar N P, Dalal A V, Tongaonkar H B, Kamat M R

机构信息

Department of Uro-oncology, Tata Memorial Hospital, Parel, Bombay, India.

出版信息

Eur J Surg Oncol. 1997 Apr;23(2):157-60. doi: 10.1016/s0748-7983(97)80012-1.

Abstract

Forty-eight patients with adenocarcinoma (21 urachal and 27 non-urachal) of the bladder were treated at the Tata Memorial Hospital between 1976 and 1992. The study group consisted of 32 men and 16 women. The urachal tumours were more common in younger patients (mean age: 49 years) than were non-urachal tumours (mean age: 58 years). The overall 5-year survival in this series was 37%. Stage and grade were powerful predictors of outcome. Patients with non-urachal tumours showed an overall survival rate of 29.9% compared with 45.7% in patients with urachal tumours (P= 0.14). Radical cystectomy was the most common treatment modality in patients with non-urachal tumours and yielded an overall 5-year survival of 35%. Patients with urachal tumours were treated with either partial cystectomy or radical cystectomy. The 5-year survival following partial cystectomy was 56.3% compared with 25.9% following a radical cystectomy and the difference between the two was not statistically significant (P = 0.76).

摘要

1976年至1992年间,塔塔纪念医院收治了48例膀胱腺癌患者(脐尿管癌21例,非脐尿管癌27例)。研究组包括32名男性和16名女性。脐尿管肿瘤在年轻患者中(平均年龄:49岁)比非脐尿管肿瘤(平均年龄:58岁)更常见。该系列的总体5年生存率为37%。分期和分级是预后的有力预测指标。非脐尿管肿瘤患者的总体生存率为29.9%,而脐尿管肿瘤患者为45.7%(P = 0.14)。根治性膀胱切除术是治疗非脐尿管肿瘤患者最常用的治疗方式,总体5年生存率为35%。脐尿管肿瘤患者接受了部分膀胱切除术或根治性膀胱切除术。部分膀胱切除术后的5年生存率为56.3%,根治性膀胱切除术后为25.9%,两者之间的差异无统计学意义(P = 0.76)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验